AnalysisBusinessOctober 20, 2026

Citrini bets on life sciences stocks after Claude Science drug study

Read original source →bloomberg.com

Citrini Research says life sciences companies stand to gain from an AI-driven surge in drug discovery after testing Anthropic's Claude Science. The firm's call is a research bet, not a disclosed position size or timeline.

1 source

More stories today

Open the live feed